Tag Archive for: SynBio

Waste based biosurfactants producer Amphistar BV has closed a €6m funding round led by the  European Circular Bioeconomy Fund (ECBF), Qbic III and Flanders Future Tech Fund (FFTF).

Mark Kotter, Cambridge, Picture:  © Bit.bio

At a recent event researcher and founder of Bit.bio, Prof. Mark Kotter, Babraham Research Campus in Cambridge/UK, was asked what healthcare looks like in 2050. He gave a twofold answer, that it will be driven by data, but also will be personalised. Mark Kotter elaborates here in more detail what is needed to unlock a healthcare of tomorrow.

© Stephanie Kath-Schorr

German researchers for the first time have expanded the half life of oligonucleotide-based drugs using artificial building blocks that mimic the features of RNA/DNA but are not digestible by enzymes.

Amplys team around CEO Ben Thomas (4th from left). © Amply Discovery Ltd

Belfast-based techbio company AMPLY Discovery Ltd announced today will make use of a £1.4m in grant funding to advance its AI-based drug discovery platform.

©UK.gov

On the occasion of SynbiTECH in London, British Science, Research and Innovation Minister, Andrew Griffith, unveiled a £2bn strategic 10-year plan to foster engineering biology.

Ambient noise does not trigger insulin secretion (left). Direct exposure of the cells to certain rock songs, on the other hand, triggers insulin release within minutes (right). © ETH Zurich

ETH Zurich researchers have developed a gene switch that triggers insulin release in designer cells by playing music.